Blog
Epitalon: telomerase in cultured cells is not a longevity trial
Telomere-related measurements help investigate mechanisms but cannot independently validate an anti-aging claim. Changing a cellular marker and demonstrating meaningful health improvement are different achievements.
Evidence discussed: Cell-culture study.
What the researchers studied
A brief experimental report examined Epithalon, a name used for Epitalon, in human fetal fibroblast culture. The authors reported activation of telomerase-related processes and longer telomeres after exposure. [1]
How to interpret the result
These were cultured cells, not people receiving an intervention. The experiment did not measure human lifespan, frailty or long-term safety. Suggestions about organism-level effects extend beyond the directly measured cell endpoints.
What readers can take from it
Telomere-related measurements help investigate mechanisms but cannot independently validate an anti-aging claim. Changing a cellular marker and demonstrating meaningful health improvement are different achievements.
This original editorial summary provides no diagnosis, dosing or treatment advice. The study did not test or certify a PeptiKing product.
Source
[1] Khavinson et al., Epithalon in somatic-cell culture (2003). PMID: 12937682. Based on the PubMed-indexed abstract and record; full-text methods were not independently reviewed.